Clinical trial
The Efficacy and Safety of Tumor Treatment Vaccine in Patients With Advanced Solid Tumors
NCT05747339 is registered in ClinicalTrials.gov with Wuxi People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Tumor Treatment Vaccine in Patients With Advanced Solid Tumors
- Lead sponsor
- Wuxi People's Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 7, 2023
- Completion date
- December 31, 2024
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumors, adult